Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
Clinical trial NCT03271515 · UNKNOWN
Trial details
- NCT number
- NCT03271515
- Sponsor
- Beijing Doing Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.